WHO ICTRP trial

A Postmarketing Clinical follow up observational study to evaluate safety and…

CTRI/2021/10/037105 · Clinical Trials Registry India (CTRI) · Recruiting

Key facts

Trial ID CTRI/2021/10/037105
Public title A Postmarketing Clinical follow up observational study to evaluate safety and effectiveness of hydrophilic acrylic (intraocular) lens.CT ASPHINA 509 M/MP
Scientific title Retro-prospective evaluation of the clinical safety and effectiveness of hydro- philic acrylic intraocular lens - UVEA 509
Primary sponsor Carl Zeiss Meditec AG
Registry Clinical Trials Registry India (CTRI)
Recruitment status Recruiting
Study type PMS
Phase Post Marketing Surveillance
Countries India;France;Spain
Conditions Health Condition 1: H270- Aphakia
Interventions Intervention1: CT ASPHINA 509M/MP: The intraocular lens CT ASPHINA 509M/MP is intended for implantation in the capsular bag to replace the human crystalline lens Intervention2: ASPHINA 509 BER-401-20 : Mfg By: Carl Zeiss Meditec AG…
Registration date May 10, 2021
Target size 325
Secondary IDs ASPHINA 509 BER-401-20 Version v3 dated 30.06.2021
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations